Leading companies in the neurovascular market include:
Asahi Intecc Co Ltd
Integer Holdings Corporation
Johnson & Johnson Services
Kaneka Medix Corp
Medtronic
MicroPort Scientific Corporation
Merit Medical System
Penumbra Inc
Stryker,
Terumo Corporation.
Authors:
Mariam Faizullabhoy
Frequently Asked Questions (FAQ) :
Global market for neurovascular devices was valued at USD 3.9 billion in 2022 and is poised to exhibit a 6.5% CAGR from 2023 to 2032 due to the surging prevalence of ischemic strokes and brain aneurysm across North America.
The neurovascular devices market from the flow diverters segment is estimated to witness a 7.5% CAGR through 2032, attributed to an increased cognizance of distinctive treatment options for intracranial aneurysm.
The ischemic stroke segment amassed over 40% of the global market share in 2022, given the growing prevalence of ischemic strokes and the rising popularity of minimally invasive procedures.
Notable firms in the neurovascular devices industry include Asahi Intecc Co. Ltd., Integer Holdings Corporation, Johnson & Johnson Services, Kaneka Medix Corp. Medtronic, MicroPort Scientific Corporation, Merit Medical System, Penumbra, Inc., Stryker, and Terumo Corporation.